SMS Pharmaceuticals Ltd. (SMSPHARMA) 52 Week High Streak: Second Straight Session Holds Focus

Updated: 15 Sept 2026 • 9:42 am

Posted by:

SMS Pharmaceuticals Ltd. (SMSPHARMA) 52 Week High Streak: Second Straight Session Holds Focus

SMS Pharmaceuticals Ltd. (SMSPHARMA) share price reached a fresh 52-week high of Rs 482.45 today and later stood at Rs 446.3, down 3.88% from the previous close. Market cap was Rs 4,348.26 crore.

SMS Pharmaceuticals Ltd. has now set a fresh 52-week high for its second straight session, and the streak is up 6.48% across the two-session run. The latest peak was Rs 482.45, while the stock last traded at Rs 446.3. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.

As of 15 September 2026 at 9:22 AM IST, the stock was below its previous close of Rs 464.3 after opening at Rs 470 and touching an intraday low of Rs 445.95. Turnover stood at Rs 2.1 crore and market capitalisation at Rs 4,348.26 crore. For readers, a repeated high matters differently from a one-day breakout because it shows the pattern has persisted across sessions, not just one intraday move.

Table of Contents

SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 446.3
Previous Close	Rs 464.3
Today's Move	Rs -18 (-3.88%)
Open	Rs 470
High	Rs 482.45
Low	Rs 445.95
Turnover	Rs 2.1 crore
Market Capitalisation	Rs 4,348.26 crore

SMS Pharmaceuticals Ltd. (SMSPHARMA) traded at Rs 446.3 versus the previous close of Rs 464.3, a fall of 3.88%. The stock opened at Rs 470, reached a high of Rs 482.45 and touched a low of Rs 445.95.

SMS Pharmaceuticals Ltd. share price today is trading lower than the previous close, with the stock at Rs 446.3 versus Rs 464.3 in the prior session. That reflects a decline of Rs 18, or 3.88%, from the previous close. The session opened at Rs 470, touched a high of Rs 482.45 and a low of Rs 445.95, which means the price is now nearer the day’s lower end than the day’s high.

This move comes after the stock had already marked a fresh 52-week high, so the key point is not only the one-day change but the fact that SMS Pharmaceuticals Ltd. has continued to print a new one-year peak for a second straight session. Turnover was Rs 2.1 crore, while market capitalisation was Rs 4,348.26 crore. For investors tracking SMSPHARMA share price today, the immediate read is a stock that remains in the news today because of the streak rather than any single-session price print.

SMS Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis

SMS Pharmaceuticals Ltd. has now set a fresh 52-week high for a second straight session, and that is the central fact behind the current SMSPHARMA 52 Week High Streak. The cumulative gain across the streak is 6.48%, which gives a fuller picture than the latest quote alone. The latest peak of Rs 482.45 also matters because it extends the prior one-year high rather than merely matching it.

Because the latest Univest data confirms the pattern but does not assign a catalyst, the repeated high should be read as a market price event first and a news event second. The stock’s renewed one-year high also means the current SMS Pharmaceuticals Ltd. share price update remains part of the broader “Stocks Hitting 52 Week Highs” and “Stocks At One Year High Today” conversation. What stands out is the persistence of the move across sessions, not a one-off print.

What the Repeated 52-Week Highs Show

The repeated highs show that SMS Pharmaceuticals Ltd. has sustained its position near the upper end of its recent price range across more than one session. The streak is now clearly established, and the current reading keeps SMSPHARMA in the category of stocks at one-year high today. That makes the move more notable than a single-day high because the market has continued to reprice the stock at new levels on successive sessions.

At the same time, the available numbers do not establish why the stock has kept setting new highs. There is no confirmed company-specific trigger in the figures, so it is better to describe the pattern as confirmed and the reason as unconfirmed. For readers looking at SMSPHARMA stock performance, the practical takeaway is that a back-to-back 52-week high sequence often draws attention to the stock price, but the facts here only support the price pattern itself. The focus keyword SMS Pharmaceuticals Ltd. 52 Week High Streak therefore reflects the real event more accurately than a one-day breakout headline would.

SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,348.26 crore
P/E Ratio	42.46x
P/B Ratio	5.39x
ROE	11.91%
ROCE	12.55%
EPS	Rs 10.93
Book Value Per Share	Rs 86.06
Dividend Yield	0.09%

SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 42.46x, P/B 5.39x, ROE 11.91%, ROCE 12.55%. These figures provide context only and are not a buy or sell signal.

SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 4348.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.46x, P/B at 5.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.91% and ROCE of 12.55%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.41x, median ROE of 11.61%, median ROCE of 13.43%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.46x
Benchmark Median P/E	32.41x
Benchmark Average P/E	49.19x
Benchmark P/E Range	3.34x to 693.7x
Company P/B Ratio	5.39x
Benchmark Median P/B	3.04x
Company ROE	11.91%
Benchmark Median ROE	11.61%
Company ROCE	12.55%
Benchmark Median ROCE	13.43%
Company Market Capitalisation	Rs 4,348.26 crore
Benchmark Median Market Cap	Rs 692.38 crore

SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.46x, which is above the benchmark median of 32.41x, a difference of +31.01%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 11.91%, which is above the benchmark median of 11.61%, a difference of +2.58%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 12.55%, which is below the benchmark median of 13.43%, a difference of -6.55%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Gufic Biosciences Ltd.	GUFICBIO	4,254.49	57.92	6.19	10.14	12.56
RPG Life Sciences Ltd.	RPGLIFE	4,456.85	38.7	7.01	20.28	26.99
Aarti Drugs Ltd.	AARTIDRUGS	3,909.55	20.45	2.45	12.68	13.11
Unichem Laboratories Ltd.	UNICHEMLAB	3,783.96	12.42	1.37	9.81	10.68
Kwality Pharmaceuticals Ltd.	KPL	3,779.53	46.63	10.6	22.67	24.01

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.46x compared with the displayed peer median of 38.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.91% compares with a peer median of 12.68% across the companies shown in the table. ROCE stood at 12.55% versus the displayed peer median of 13.11%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 4,348.26 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals Ltd. has set a fresh 52-week high for a second straight session.
The cumulative move across the streak is 6.48%.
The latest 52-week high stood at Rs 482.45.
Valuation remains a key talking point, with P/E at 42.46 and P/B at 5.39.
The stock is being compared with other Pharmaceuticals & Drugs names in the Healthcare sector.

About SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry, and it is listed on NSE and BSE under the symbol SMSPHARMA. The company’s market capitalisation is Rs 4,348.26 crore, placing it within a competitive set of mid-sized listed pharmaceutical names by market value in the peer sample.

For readers following SMS Pharmaceuticals Ltd. stock performance, the current focus is on how the repeated 52-week high streak fits with the company’s valuation, profitability ratios and peer positioning. The latest prices and market-cap figures are the main reference points available for tracking the stock from here.

Track SMS Pharmaceuticals Ltd. on Univest

Track SMS Pharmaceuticals Ltd. on Univest to follow the latest SMSPHARMA share price, stock news and company updates. The stock page can help readers monitor the next market move after this second straight session of fresh 52-week highs, along with future valuation and sector comparisons.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What does SMS Pharmaceuticals Ltd. 52 Week High Streak mean?

Ans. It means SMS Pharmaceuticals Ltd. has set a fresh 52-week high on consecutive sessions. In this case, the streak is for a second straight session, which makes the one-year high pattern more notable than a single-day breakout.

How many sessions has SMSPHARMA made a fresh 52-week high?

Ans. SMS Pharmaceuticals Ltd. has made a fresh 52-week high for two consecutive sessions. The latest streak label is second straight session, and the cumulative move across that run is 6.48%.

What is the latest 52-week high for SMS Pharmaceuticals Ltd.?

Ans. The latest 52-week high for SMS Pharmaceuticals Ltd. is Rs 482.45. The stock touched that level during the current streak, which is why the move is being tracked as a repeated one-year high event.

Is a company-specific catalyst confirmed for the streak?

Ans. No company-specific catalyst is confirmed by the latest Univest figures. The data confirms the repeated-high price pattern, but it does not establish why the stock has continued to set new highs.

How is SMSPHARMA valued compared with its industry?

Ans. SMS Pharmaceuticals Ltd. trades at a P/E of 42.46 and a P/B of 5.39. That places it above the industry median on both counts, so valuation is an important part of the stock’s current story.

What do the profitability ratios show?

Ans. SMS Pharmaceuticals Ltd. reports ROE of 11.91% and ROCE of 12.55%. ROE is close to the industry median, while ROCE is slightly below the industry median, so the return profile is mixed.

Why is the stock being watched now?

Ans. The stock is being watched because it has set back-to-back 52-week highs and remains in the, Stocks Hitting 52 Week Highs, conversation. Investors are also comparing its valuation, returns and peer positioning.

What should investors monitor next?

Ans. Investors should monitor the next price print, whether the repeated-high pattern continues, and how the stock is valued versus peers. The latest share price, market capitalisation and industry multiples are the key reference points now.